Abstract | BACKGROUND AND PURPOSE: METHODS: We recruited control patients (n=85) and those with LAA stroke (n=141) according to the TOAST classification system. The modified Rankin scale at 3 months after stroke was used to evaluate the prognosis. The prognostic accuracy was assessed by the receiver operating characteristic curve. RESULTS: Serum YKL-40 level was significantly higher for LAA patients than for controls (P<.001). Patients with poor outcomes (n=36) had significantly increased serum YKL-40 concentrations on admission (P=.01). High YKL-40 levels predicted poor functional outcome (OR=6.47, P=.02). Moreover, the combination of YKL-40 level and the NIHSS score could improve the prognostic accuracy of the NIHSS in predicting functional outcome (combined areas under the curve, 0.87; 95% CI, 0.80-0.94; P<.001). CONCLUSIONS: The level of serum YKL-40 is a significant and independent biomarker to predict the clinical outcome of LAA stroke.
|
Authors | X-L Chen, Q Li, W-S Huang, Y-S Lin, J Xue, B Wang, K-L Jin, B Shao |
Journal | Acta neurologica Scandinavica
(Acta Neurol Scand)
Vol. 136
Issue 2
Pg. 97-102
(Aug 2017)
ISSN: 1600-0404 [Electronic] Denmark |
PMID | 27650381
(Publication Type: Journal Article)
|
Copyright | © 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Biomarkers
- CHI3L1 protein, human
- Chitinase-3-Like Protein 1
|
Topics |
- Adult
- Aged
- Atherosclerosis
(blood, diagnostic imaging, epidemiology)
- Biomarkers
(blood)
- Cerebral Arteries
(diagnostic imaging)
- China
(epidemiology)
- Chitinase-3-Like Protein 1
(blood)
- Female
- Humans
- Male
- Middle Aged
- Prognosis
- Stroke
(blood, diagnostic imaging, epidemiology)
|